A detailed history of Abrdn PLC transactions in Personalis, Inc. stock. As of the latest transaction made, Abrdn PLC holds 3,249,895 shares of PSNL stock, worth $25.4 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,249,895
Previous 2,387,947 36.1%
Holding current value
$25.4 Million
Previous $14.8 Million 71.71%
% of portfolio
0.04%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 16, 2026

BUY
$6.74 - $10.12 $5.81 Million - $8.72 Million
861,948 Added 36.1%
3,249,895 $25.4 Million
Q3 2025

Nov 06, 2025

BUY
$4.38 - $7.51 $2.75 Million - $4.72 Million
628,450 Added 35.72%
2,387,947 $14.8 Million
Q2 2025

Jul 24, 2025

BUY
$3.0 - $6.57 $164,139 - $359,464
54,713 Added 3.21%
1,759,497 $11.5 Million
Q1 2025

May 13, 2025

BUY
$3.51 - $6.64 $4.94 Million - $9.34 Million
1,406,895 Added 472.29%
1,704,784 $5.98 Million
Q4 2024

Jan 24, 2025

BUY
$3.38 - $6.26 $1.01 Million - $1.86 Million
297,889 New
297,889 $1.72 Million

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $359M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Abrdn PLC Portfolio

Follow Abrdn PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.